121 related articles for article (PubMed ID: 18406916)
21. Controversies and new developments in gynecologic brachytherapy: image-based intracavitary brachytherapy for cervical carcinoma.
Nag S
Semin Radiat Oncol; 2006 Jul; 16(3):164-7. PubMed ID: 16814157
[TBL] [Abstract][Full Text] [Related]
22. Prostate displacement kit: reducing the radiation dose to the rectum.
Kälkner KM; Nilsson J; Lundell M; Levitt S; Nilsson S
Radiother Oncol; 2006 Dec; 81(3):291-3. PubMed ID: 17125860
[TBL] [Abstract][Full Text] [Related]
23. The importance of urethra visualization for preplanned permanent prostate implants.
Sloboda RS; Pedersen JE
Brachytherapy; 2005; 4(3):195-201. PubMed ID: 16182219
[TBL] [Abstract][Full Text] [Related]
24. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
Vordermark D; Guckenberger M; Baier K; Markert K
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
[No Abstract] [Full Text] [Related]
25. Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group.
Bice WS; Prestidge BR; Kurtzman SM; Beriwal S; Moran BJ; Patel RR; Rivard MJ;
Brachytherapy; 2008; 7(4):290-6. PubMed ID: 18782682
[TBL] [Abstract][Full Text] [Related]
26. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
[TBL] [Abstract][Full Text] [Related]
27. AAPM Task Group 128: quality assurance tests for prostate brachytherapy ultrasound systems.
Pfeiffer D; Sutlief S; Feng W; Pierce HM; Kofler J
Med Phys; 2008 Dec; 35(12):5471-89. PubMed ID: 19175107
[TBL] [Abstract][Full Text] [Related]
28. Options and recent advances in permanent brachytherapy for prostate cancer.
Marshall DT
Can J Urol; 2007 Dec; 14 Suppl 1():28-31. PubMed ID: 18163942
[TBL] [Abstract][Full Text] [Related]
29. Calculation of brachytherapy doses does not need TG-43 factorization. For the proposition.
Song H
Med Phys; 2003 Jun; 30(6):997-8. PubMed ID: 12852519
[No Abstract] [Full Text] [Related]
30. Developing quality assurance processes for image-guided adaptive radiation therapy.
Yan D
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S28-32. PubMed ID: 18406933
[TBL] [Abstract][Full Text] [Related]
31. Standardization and automation of quality assurance for high-dose-rate brachytherapy planning with application programming interface.
Cai B; Altman MB; Reynoso F; Garcia-Ramirez J; He A; Edward SS; Zoberi I; Thomas MA; Gay H; Mutic S; Zoberi JE
Brachytherapy; 2019; 18(1):108-114.e1. PubMed ID: 30385115
[TBL] [Abstract][Full Text] [Related]
32. Low-dose-rate brachytherapy for prostate cancer: preplanning vs. intraoperative planning-intraoperative planning is best.
Zelefsky MJ; Zaider M
Brachytherapy; 2006; 5(3):143-4; discussion 146. PubMed ID: 16864062
[No Abstract] [Full Text] [Related]
33. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
[TBL] [Abstract][Full Text] [Related]
34. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy in the management of clinically localized prostate cancer: evolving standards, consensus, controversies and new directions.
Speight JL; Roach M
J Clin Oncol; 2005 Nov; 23(32):8176-85. PubMed ID: 16278470
[TBL] [Abstract][Full Text] [Related]
36. Quality assurance of I-125 seeds for prostate brachytherapy using an imaging plate.
Furutani S; Saze T; Ikushima H; Oita M; Ozaki K; Kishida Y; Takegawa Y; Nishitani H
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):603-9. PubMed ID: 16966003
[TBL] [Abstract][Full Text] [Related]
37. Medical aspects of quality assurance in brachytherapy.
Kovács G
Strahlenther Onkol; 1998 Oct; 174 Suppl 2():47-9. PubMed ID: 9810339
[TBL] [Abstract][Full Text] [Related]
38. Improving prostate brachytherapy by developing image guidance.
Acher PL; Dasgupta P; Popert R
BJU Int; 2007 Feb; 99(2):241-3. PubMed ID: 17313419
[No Abstract] [Full Text] [Related]
39. Low-dose-rate brachytherapy for prostate cancer: preplanning vs. intraoperative planning-preplanning is best.
Blasko JC
Brachytherapy; 2006; 5(3):139-42; discussion 145. PubMed ID: 16864061
[No Abstract] [Full Text] [Related]
40. New frontiers in brachytherapy.
Nag S
Surg Oncol Clin N Am; 2000 Jul; 9(3):489-502, viii-ix. PubMed ID: 10853138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
